IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest F-1/A SEC Filings
Registration statement for certain foreign private issuers: [Amend]

NYMOX PHARMACEUTICAL CORP, F-1/A, 2000-03-09


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission